BackChina Regenerative Medicine International Limited Overview

China Regenerative Medicine International Limited Current Cash

China Regenerative Medicine International Limited's current cash is $1.8M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.82M
↓ 75.01% YoYΔ $-5.46M vs prior year quarter

Peer trimmed avg / median

Loading

China Regenerative Medicine International Limited Current Cash History

Loading

China Regenerative Medicine International Limited vs. peers: Current Cash Comparison

Loading

China Regenerative Medicine International Limited Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

China Regenerative Medicine International Limited (8158.HK) FAQ

As of the most recent data (June 2026), 8158.HK shows a current cash of $1.8M. That compares with $7.3M in the prior-year period — down 75.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 8158.HK's current cash is now $1.8M (was $7.3M) — a 75.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether China Regenerative Medicine International Limited is outperforming or lagging.

Tracking 8158.HK's current cash over time shows whether China Regenerative Medicine International Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8M That compares with $7.3M in the prior-year period — down 75.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has China Regenerative Medicine International Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.8M) with ownership activity and broader fundamentals.

China Regenerative Medicine International Limited's current cash is $1.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.